Dalena Capital Fund I, LP
Raising: Form D filed May 2026 reports amount sold below target
- Vintage
- 2025
- Fund size
- $2.55M to $5M (Form D)
- Stages
- Seed
- Sectors
- Biotech
- Regions
- Not stated
01 · Thesis
Dalena Capital backs seed-stage companies translating breakthrough science into novel medicines, combining world-class science, early-stage capital, and operational discipline to support founders building life-changing medicines.Inferred from the firm's website
02 · Initial check
$26K to $83K (estimated from fund size)
Estimated from Form D: $2.55M sold of a $5M target
03 · Who to approach
Named on this fund's Form D
- Katherine Moortgat, Managing Partner of the Manager of the General Partner of the Fund
04 · Deals
No deals attributed to this fund yet.
05 · Evidence
Firm-wideDalena Capital aims to build an ecosystem where science, early-stage capital, and operational discipline support founders creating life-changing medicines. It focuses on seed-stage companies translating breakthrough science into novel medicines.
At Dalena Capital, we are building an enduring ecosystem where world-class science, early-stage capital, and operational discipline converge to support founders creating life-changing medicines.
https://dalena.vc/
06 · Sources
Last verified: Oct 28, 2026